Colorectal cancer: open trials in Denmark

• NCT04929223

  A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  Trial Treatment · Phase 1 · Hoffmann-La Roche

  Rigshospitalet, Copenhagen Oe · Herlev og Gentofte Hospital, Herlev

  Registry updated 2026-11-06

• NCT07549412

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  Trial Treatment · Phase 3 · EMD Serono Research & Development Institute, Inc.

  Aalborg University Hospital, Aalborg · Region Hovedstaden, Herlev · Lillebaelt Hospital, Vejle

  Registry updated 2026-11-05

• NCT06760819

  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 2 · Bayer

  Aarhus University Hospital | Oncology Department - Clinical Research Unit, Aarhus N · Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense

  Registry updated 2026-11-04

• NCT07687875

  Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer

  Trial Treatment · Phase 1 · Henry Smith

  Copenhagen University Hospital, Copenhagen Nv

  Registry updated 2026-11-04

• NCT07284849

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  Trial Treatment · Phase 3 · Incyte Corporation

  Aalborg University Hospital, Aalborg · Odense University Hospital, Odense C · Region Sjaelland, Roskilde · Lillebaelt Hospital, Vejle

  Registry updated 2026-10-30

• NCT07903883

  Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer

  Trial Treatment · University of Aarhus

  Aalborg University Hospital, Aalborg · Danish Centre for Particle Therapy, Aarhus · Aarhus University Hospital, Aarhus · Rigshospitalet, Copenhagen · Herlev Hospital, Herlev · Zealand University Hospital, Naestved, Næstved · Odense University Hospital, Odense · Vejle Hospital, Vejle

  Registry updated 2026-10-29

• 2026-525883-17-00

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  Trial Treatment · Phase 3 · Genmab A/S

  Region Nordjylland, Aalborg · Region Syddanmark, Odense C

  Registry updated 2026-10-26

• NCT06004245

  A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  Trial Treatment · Phase 1 · Vividion Therapeutics, Inc.

  Rigshospitalet, København Ø

  Registry updated 2026-10-21

• NCT06802991

  Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)

  Trial Treatment · Copenhagen University Hospital at Herlev

  University Hospital Herlev, Herlev

  Registry updated 2026-10-21

• NCT05786924

  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Trial Treatment · Phase 1/2 · Institut de Recherches Internationales Servier

  Center for Cancer and Organ Diseases - Rigshospitalet, Copenhagen

  Registry updated 2026-10-13

• NCT07023289

  A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

  Trial Treatment · Phase 2 · AbbVie

  Region Midtjylland, Aarhus N · Odense University Hospital, Odense C · Sygehus Lillebaelt - Vejle Sygehus, Vejle

  Registry updated 2026-10-09

• NCT07261631

  Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

  Trial Treatment · Phase 1 · Novartis Pharmaceuticals

  Odense C

  Registry updated 2026-10-09

• NCT07222800

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  Trial Treatment · Phase 3 · Pfizer

  Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Vejle Hospital, Vejle

  Registry updated 2026-10-08

• NCT07535112

  A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

  Trial Treatment · Phase 1 · Bayer

  Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense

  Registry updated 2026-10-05

• 2025-524160-38-00

  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Region Hovedstaden, Herlev

  Registry updated 2026-10-01

• NCT06645015

  The AIDPRO-CRC Trial

  Trial Treatment · Zealand University Hospital

  Aalborg University Hospital, Department of Gastrointestinal Surgery, Aalborg · Bispebjerg Hospital, University of Copenhagen, Digestive disease Center, Department of Surgery, Copenhagen NV · Regional Hospital Gødstrup, Department of Surgery, Herning · Copenhagen University Hospital - North Zealand, Hillerød, Department of Surgery, Hillerød · Copenhagen University Hospital Hvidovre, Gastro Unit, Surgical Division, Hvidovre · Regional Hospital Randers, Department of Surgery, Randers · Odense University Hospital, Svendborg, Department of Colorectal Surgery, Svendborg · Viborg Regional Hospital, Hospitalunit Midt, Department of Surgery, Viborg

  Registry updated 2026-09-17

• NCT07213609

  A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  Trial Treatment · Phase 1/2 · GlaxoSmithKline

  København Ø

  Registry updated 2026-09-16

• 2025-521702-18-00

  A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

  Trial Treatment · Phase 1 · Novartis Pharma AG

  Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-09-15

• NCT07799740

  Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging

  Trial Treatment · University of Aarhus

  Regional Hospital Gødstrup, Herning · Sygehus Lillebælt, Vejle Hospital, Vejle

  Registry updated 2026-09-11

• NCT06252649

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  Trial Treatment · Phase 3 · Amgen

  Aalborg Sygehus, Aalborg · Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen · Odense University Hospital, Odense C

  Registry updated 2026-09-03

• NCT07630961

  Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

  Trial Treatment · Phase 1 · Novartis Pharmaceuticals

  Odense C

  Registry updated 2026-08-27

• NCT07237984

  Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway

  Research · Nordsjaellands Hospital

  Copenhagen University Hospital - North Zealand, Hillerød · Copenhagen University Hospital - Amager-Hvidovre, Hvidovre

  Registry updated 2026-08-24

• 2022-502352-31-00

  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  Trial Treatment · Phase 3 · Amgen Inc.

  Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-07-30

• NCT07094113

  AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 1 · Amgen

  Rigshospitalet, Copenhagen

  Registry updated 2026-07-30

• NCT06714318

  SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening

  Research · Vejle Hospital

  Hospital Sønderjylland, Aabenraa · Vejle Hospital, Vejle

  Registry updated 2026-06-29

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error